These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 20509750
1. Metabolic profiles of difluprednate in rabbit ocular tissues after instillation of difluprednate ophthalmic emulsion. Tajika T, Takahashi H, Sakai Y, Fujii H, Isowaki A, Sakaki H. Xenobiotica; 2010 Aug; 40(8):569-77. PubMed ID: 20509750 [Abstract] [Full Text] [Related]
2. Pharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassay. Tajika T, Waki M, Tsuzuki M, Kida T, Sakaki H. J Ocul Pharmacol Ther; 2011 Feb; 27(1):29-34. PubMed ID: 21182429 [Abstract] [Full Text] [Related]
3. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits. Tajika T, Isowaki A, Sakaki H. J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027 [Abstract] [Full Text] [Related]
4. Analysis of an anti-inflammatory steroidal drug, difluprednate, in aqueous humor by combination of semi-micro HPLC and column switching method. Yasueda S, Kimura M, Ohtori A, Kakehi K. J Pharm Biomed Anal; 2003 Jan 15; 30(6):1735-42. PubMed ID: 12485714 [Abstract] [Full Text] [Related]
5. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Yamaguchi M, Yasueda S, Isowaki A, Yamamoto M, Kimura M, Inada K, Ohtori A. Int J Pharm; 2005 Sep 14; 301(1-2):121-8. PubMed ID: 16023810 [Abstract] [Full Text] [Related]
6. Ocular disposition of aminozolamide in the rabbit eye. Putnam ML, Schoenwald RD, Duffel MW, Barfknecht CF, Segarra TM, Campbell DA. Invest Ophthalmol Vis Sci; 1987 Aug 14; 28(8):1373-82. PubMed ID: 3610554 [Abstract] [Full Text] [Related]
7. Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate. Mercado-Sesma A, Contreras-Rubio A, Baiza-Durán L, Olvera-Montaño O, Miranda-Robles M, Bonilla-García J. J Ophthalmic Inflamm Infect; 2017 Dec 14; 7(1):10. PubMed ID: 28324274 [Abstract] [Full Text] [Related]
8. Intraocular production and release of nerve growth factor after iridectomy. Lambiase A, Bonini S, Manni L, Ghinelli E, Tirassa P, Rama P, Aloe L. Invest Ophthalmol Vis Sci; 2002 Jul 14; 43(7):2334-40. PubMed ID: 12091435 [Abstract] [Full Text] [Related]
9. Lack of prostaglandin F2 alpha metabolism by human ocular tissues. Cheng-Bennett A, Poyer J, Weinkam RJ, Woodward DF. Invest Ophthalmol Vis Sci; 1990 Jul 14; 31(7):1389-93. PubMed ID: 2365570 [Abstract] [Full Text] [Related]
10. Comparison of early posttreatment effects of two steroidal anti-inflammatory ophthalmic drugs on the ocular inflammatory response induced by paracentesis in healthy canine eyes. Sato K, Iwasaki K, Nagai N, Yamashita Y, Chikazawa S, Hoshi F, Kanai K. Vet Ophthalmol; 2019 Sep 14; 22(5):607-613. PubMed ID: 30716193 [Abstract] [Full Text] [Related]
11. The ocular penetration of topical forskolin and its effects on intraocular pressure, aqueous flow rate and cyclic AMP level in the rabbit eye. Matsumoto S, Yamashita T, Araie M, Kametani S, Hosokawa T, Takase M. Jpn J Ophthalmol; 1990 Sep 14; 34(4):428-35. PubMed ID: 1964483 [Abstract] [Full Text] [Related]
12. Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery. Verhoeven RS, Garcia A, Robeson R, Gilger BC, Culp D, Struble C, Hamm L, Navratil T, Yerxa B. J Ocul Pharmacol Ther; 2018 Sep 14; 34(1-2):161-169. PubMed ID: 28650720 [Abstract] [Full Text] [Related]
13. Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys. Proksch JW, Lowe ER, Ward KW. Drug Metab Dispos; 2011 Jul 14; 39(7):1181-7. PubMed ID: 21441467 [Abstract] [Full Text] [Related]
14. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats. Fukano Y, Kawazu K. Drug Metab Dispos; 2009 Aug 14; 37(8):1622-34. PubMed ID: 19477946 [Abstract] [Full Text] [Related]
15. Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits. Kakimoto H, Takamura Y, Arimura S, Miyake S, Matsumura T, Gozawa M, Iwasaki K, Morioka M, Yamada Y, Inatani M. J Ocul Pharmacol Ther; 2018 Jun 14; 34(5):410-415. PubMed ID: 29812993 [Abstract] [Full Text] [Related]
16. Metabolites of isopropyl unoprostone as potential ophthalmic solutions to reduce intraocular pressure in pigmented rabbits. Kashiwagi K, Iizuka Y, Tsukahara S. Jpn J Pharmacol; 1999 Sep 14; 81(1):56-62. PubMed ID: 10580371 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of topical ocular phenylephrine HCl. Antoine ME, Edelhauser HF, O'Brien WJ. Invest Ophthalmol Vis Sci; 1984 Jan 14; 25(1):48-54. PubMed ID: 6698730 [Abstract] [Full Text] [Related]
18. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution. Fukuda M, Inoue A, Sasaki K, Takahashi N. Jpn J Ophthalmol; 2004 Jan 14; 48(2):93-6. PubMed ID: 15060787 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of terbinafine in the rabbit ocular tissues after topical administration. Sun XG, Wang ZX, Wang ZQ, Deng SJ, Li R, Luo SY, Wu YY. Ophthalmic Res; 2007 Jan 14; 39(2):81-3. PubMed ID: 17284933 [Abstract] [Full Text] [Related]
20. [Ocular pharmacokinetics of pilocarpine micron emulsion in rabbits]. Xu Y, Chen Z, Song J, Zhang J, Xie L. Zhonghua Yan Ke Za Zhi; 1999 Nov 14; 35(6):446-8. PubMed ID: 11835858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]